In disorders such as rheumatoid arthritis (RA), osteoarthritis (OA), phlebitis, and IBD, GBP5 activates the NLRP3 inflammasome, thereby increasing IL-1β and IL-18 production, which exacerbates local inflammation (55, 138, –, 140). Here, GBP5 is linked to inflammatory bowel disease.